BAL Lazio

HTA

HTA – Documenti

Pubblicato lunedì 5 Maggio 2014

ITALIA

Ricciardi W, Agostinelli A, La Torre G, Cicchetti A, Derrico P, Paternello F, ViHTA Project Team. Primo Libro Bianco sull’Health Technology Assessment in Italia. (PDF 2499 KB) Progetto ViHTA. Valore in Health Technology Assessment 2010. Istituto d’Igiene, Università Cattolica del Sacro Cuore.

Ministero della salute. Direzione generale dei medicinali e dei dispositivi medici. Dispositivi medici. Aspetti regolatori e operativi, II edizione, Roma 2010.

Ministero della Salute: Sicurezza dei pazienti e gestione del rischio clinico: Manuale per la formazione degli operatori sanitari (PDF 742 KB), 2007.

Agenas
I report HTA a cura dell’age.na.s.
Supporto per gli acquisti di tecnologie sanitarie e monitoraggio prezzi, 2012. Accordo di collaborazione Regione Friuli Venezia Giulia – Direzione centrale salute integrazione sociosanitaria e politiche sociali. Agenas – Agenzia nazionale per i servizi sanitari regionali.

RESTO DEL MONDO
Goodman CS. HTA 101: Introduction to Health Technology Assessment. National Library of Medicine.The Lewin Group Falls Church, Virginia, USA, 2004.

Murphy E, Dingwall R, Greatbatch D, Parker S, Watson P. Qualitative research methods in health technology assessment: a review of the literature. Health Technol Assess 1998; 2: 1-274.

NICE – National Institute for Health and Clinical Excellence. A guide for patient/carer groups – Contributing to a technology appraisal (PDF, 114 KB), 2004.

Topfer LA, Auston I. E-text on Health Technology Assessment (HTA) information resources. National Information Centre on Health Services Research and Health Care Technology (NICHSR), 2003. First published: 01 January 2002 Last updated: 18 May 2004 Date Archived: 05 September 2006.

Velasco Garrido M, Borlum Kristiensen F, Palmhoj Nielsen C, Busse R, eds. Health technology assessment and health policy making in Europe. (PDF, 1239 KB) Copenhagen: European Observatory-WHO, 2008.

Archiviato in ,

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *

Accedi agli articoli

Currie JM et al. Prescribing of opioid analgesics and buprenorphine for opioid use disorder during the covid-19 pandemic. JAMA Netw Open 2021;4(4):e216147.

Marson A, Burnside G, Appleton R, et al.; SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 2021;397(10282):1375-1386.

Marson A, Burnside G, Appleton R, et al.; SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 2021;397(10282):1363-1374.

Zichi C et al. Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review. Eur j Canc 2021;149:49-60.

Seidler AN et al.; on behalf of the International Liaison Committee On Resuscitation Neonatal Life Support Task Force. Umbilical cord management for newborns <34 weeks' gestation: a meta-analysis. Pediatrics 2021; 147 (3) e20200576.

Gabrhelík R et al. Cannabis use during pregnancy and risk of adverse birth outcomes: a longitudinal cohort study. Eur Addict Res 2020. doi: 10.1159/000510821e

Ouldali N et al. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA. February 1, 2021. Epub ahead of print. doi:10.1001/jama.2021.0694

Freedman RA et al. Individualizing surveillance mammography for older patients after treatment for early-stage breast cancer: multidisciplinary expert panel and International Society of Geriatric Oncology Consensus Statement. JAMA Oncol. Published online January 28, 2021. doi:10.1001/jamaoncol.2020.7582

Fontanella CA et al. Association of cannabis use with self-harm and mortality risk among youths with mood disorders. JAMA Pediatr. Published online January 19, 2021. doi:10.1001/jamapediatrics.2020.5494

Una finestra sull’open access

  • BMC Family Practice
  • BMC Medical Education
  • BMC Nursing
  • BMJ Open
  • PLOS Medicine

Reset della password

Per favore inserisci la tua email. Riceverai una nuova password via email.